down arrow

Zhuzhou Qianjin Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001GX3
  • SHG: 600479
CNY
13.57
1.23 (9.97%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Why is Zhuzhou Qianjin Pharmaceutical Co., Ltd. ?

1
Positive results in Jun 26
  • OPERATING CASH FLOW(Y) Highest at CNY 582.31 MM
  • DIVIDEND PAYOUT RATIO(Y) Highest at 83.72%
  • INVENTORY TURNOVER RATIO(HY) Highest at 4.19 times
2
With ROE of 12.44%, it has a very attractive valuation with a 1.50 Price to Book Value
  • Over the past year, while the stock has generated a return of 17.19%, its profits have risen by 23.2% ; the PEG ratio of the company is 0.5
3
Market Beating Performance
  • The stock has generated a return of 17.19% in the last 1 year, much higher than market (China Shanghai Composite) returns of 3.40%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Zhuzhou Qianjin Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhuzhou Qianjin Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
30.61%
0.22
43.31%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.77%
EBIT Growth (5y)
1.08%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
1.24
Tax Ratio
14.76%
Dividend Payout Ratio
57.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.59%
ROE (avg)
15.82%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.50
EV to EBIT
12.50
EV to EBITDA
9.90
EV to Capital Employed
1.51
EV to Sales
1.26
PEG Ratio
0.52
Dividend Yield
3.33%
ROCE (Latest)
12.09%
ROE (Latest)
12.44%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 582.31 MM

DIVIDEND PAYOUT RATIO(Y)

Highest at 83.72%

INVENTORY TURNOVER RATIO(HY)

Highest at 4.19 times

DIVIDEND PER SHARE(HY)

Highest at CNY 3.48

OPERATING PROFIT(Q)

Highest at CNY 160.13 MM

PRE-TAX PROFIT(Q)

Highest at CNY 143.97 MM

NET PROFIT(Q)

Highest at CNY 106.83 MM

-4What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -4.75 %

RAW MATERIAL COST(Y)

Grown by 5.54% (YoY

CASH AND EQV(HY)

Lowest at CNY 1,374.39 MM

Here's what is working for Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Operating Cash Flow
Highest at CNY 582.31 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Operating Profit
Highest at CNY 160.13 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit
Highest at CNY 143.97 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 106.83 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio
Highest at 4.19 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Dividend per share
Highest at CNY 3.48
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio
Highest at 83.72%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Debt-Equity Ratio
Highest at -4.75 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv
Lowest at CNY 1,374.39 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 5.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading